Literature DB >> 1719569

Comparative behavioral and neurochemical studies with striatal kainic acid- or quinolinic acid-lesioned rats.

L Vécsei1, M F Beal.   

Abstract

In the present studies the effects of kainic acid (KA)- or quinolinic acid (QA)-induced striatal lesions were compared in different behavioral tests in rats. Both KA- and QA-lesioned animals had ipsilateral barrel-rotation (BR). The KA-lesioned rats, however, had contralateral, while the QA-lesioned rats had both ipsi- and contralateral turning activity. The KA-lesioned animals showed increased open-field activity as well as increased percentage of entries, and time spent in the open arms of Montgomery's conflict test. Learning of an active avoidance response was strongly inhibited by both striatal QA- or KA-induced striatal lesions. The QA-lesioned animals showed less pronounced behavioral changes than KA-lesioned animals in most of the tests, and had a smaller loss of body weight. There was no significant difference in the extent of the KA- and QA-induced substance P (SP) and GABA depletions in striatum, however, the depletions with QA lesions were slightly greater. These findings show that KA-induced striatal lesions produce more pronounced behavioral effects than QA lesions of similar size. It is possible that the differential effects of KA versus QA on striatal interneurons may result in its more marked behavioral effects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719569     DOI: 10.1016/0091-3057(91)90211-j

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  7 in total

1.  Preserved fronto-striatal plasticity and enhanced procedural learning in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe.

Authors:  Silvia Middei; Raffaella Geracitano; Antonio Caprioli; Nicola Mercuri; Martine Ammassari-Teule
Journal:  Learn Mem       Date:  2004 Jul-Aug       Impact factor: 2.460

Review 2.  The kynurenine system and immunoregulation.

Authors:  Yvette Mándi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-07-09       Impact factor: 3.575

Review 3.  Involvement of kynurenines in Huntington's disease and stroke-induced brain damage.

Authors:  Trevor W Stone; Caroline M Forrest; Nicholas Stoy; L Gail Darlington
Journal:  J Neural Transm (Vienna)       Date:  2011-06-22       Impact factor: 3.575

4.  A comparison of striatal-dependent behaviors in wild-type and hemizygous Drd1a and Drd2 BAC transgenic mice.

Authors:  Alexandra B Nelson; Giao B Hang; Brad A Grueter; Vincent Pascoli; Christian Luscher; Robert C Malenka; Anatol C Kreitzer
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

Review 5.  Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies.

Authors:  D Zádori; P Klivényi; E Vámos; F Fülöp; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2009-07-18       Impact factor: 3.575

Review 6.  Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.

Authors:  Dénes Zádori; Péter Klivényi; Imola Plangár; József Toldi; László Vécsei
Journal:  J Cell Mol Med       Date:  2011-04       Impact factor: 5.310

7.  Metabolomic Characterization of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS).

Authors:  Federica Murgia; Antonella Gagliano; Marcello G Tanca; Noga Or-Geva; Aran Hendren; Sara Carucci; Manuela Pintor; Francesca Cera; Fausto Cossu; Stefano Sotgiu; Luigi Atzori; Alessandro Zuddas
Journal:  Front Neurosci       Date:  2021-05-28       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.